Andreas Scherer studied biology in Cologne, Germany, and Freiburg,Germany,                                                                   and received his Ph.D. for his studies in the fields of genetics, developmental biology, and microbiology.      

Following a postdoctoral position at UT Southwestern Medical Center in Dallas, TX, he worked for many years in pharmaceutical industry in various positions in the field of experimental and statistical biomarker discovery,

In 2007, Dr Scherer founded Spheromics, a company specialized in analytical and consultancy services in                 gene expression technologies and biomarker development.